HOME >> BIOLOGY >> NEWS
Plant protection from cold decoded

In response to cold, plants trigger a cascade of genetic reactions that allow them to survive. University of California, Riverside Professor of Plant Cell Biology Jian-Kang Zhu has described how a little-known biochemical reaction regulates that genetic cascade.

Zhu's findings were published in the May 15 online version of the Proceedings of the National Academy of Sciences in a paper titled The Negative Regulator of Plant Cold Responses, HOS1 is a RING E3 Ligase That Mediates the Ubiquitation and Degredation of ICE1. Zhu co-authored the paper with UCR colleagues Chun Hai Dong and Manu Agarwal; and Yiyue Zhang and Qi Xie, from the Institute of Genetics and Development of the Chinese Academy of Sciences in Beijing.

This negative regulator, known as high expression of osmotically responsive gene 1 (HOS1), acts essentially as a biochemical gate that cuts off the plant's cold protection, Zhu said. The HOS1 gene product interacts with another gene product known as ICE1 that kicks off the genetic cascade that provides the plant's cold protection proteins, according to the paper. The interaction worked both in the test tube and in the live plant.

"The better we understand this molecular mechanism, the better we can control the process of increasing the plant's freezing tolerance without causing negative impacts," Zhu said. "This process should apply to all plants and can help us better use crops of subtropical origin such as corn, rice, avocadoes and strawberries."

Zhu said the discovery of how HOS1 acts on plants should help his overall research efforts into how plants respond to environmental stresses such as cold, soil salinity and drought.

"From a genetic and molecular standpoint, these responses are all related," Zhu said. "Some of the same genes are involved in all of these responses and understanding how they work can help us develop crops that can better withstand these conditions."

Zhu said he plans on continuing his
'"/>

Contact: Ricardo Duran
ricardo.duran@ucr.edu
951-827-8593
University of California - Riverside
16-May-2006


Page: 1 2

Related biology news :

1. Plant diseases and issues that are of importance to Californias economy and agriculture
2. Plants recognize their siblings, biologists discover
3. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
4. Plants tag insect herbivores with an alarm
5. Plant pathologists fighting global threat to wheat supply
6. Plants with male and bisexual flowers on the same plant are better mothers
7. Plants do not emit methane
8. FSU leads botanical research into 21st century: Deep South Plant Specimen Imaging Project
9. Mother knows best: Plant knowledge key to childhood health in remote Amazon
10. Plants management of nutrient suggests environmental remedies
11. Plant size morphs dramatically as scientists tinker with outer layer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Plant protection from cold decoded

(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... 21, 2013  Personal Genome Diagnostics Inc. (PGDx), ... methodologies and expertise in genomic analysis of defined ... collaboration with Blueprint Medicines.  PGDx is an innovator ... alterations in tumors, and Blueprint Medicines is an ... a genetically defined patient population. "This ...
(Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...
(Date:5/21/2013)... Mississauga, Ontario (PRWEB) May 21, 2013 ... expert scientists of the ITN to design the ... usefulness of two key clinical models used in ... Chamber (EEC) and Nasal Allergen Challenge (NAC) models. ... supported by numerous publications, to date no direct ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: